Royal Bank of Canada’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.92B | Sell |
3,913,903
-122,343
| -3% | -$66.4M | 0.34% | 56 |
|
|
2025
Q4 | $2.34B | Buy |
4,036,246
+1,313,517
| +48% | +$743M | 0.38% | 45 |
|
|
2025
Q3 | $1.32B | Sell |
2,722,729
-593,425
| -18% | -$276M | 0.22% | 83 |
|
|
2025
Q2 | $1.34B | Buy |
3,316,154
+91,478
| +3% | +$38.2M | 0.24% | 76 |
|
|
2025
Q1 | $1.6B | Sell |
3,224,676
-47,855
| -1% | -$25.9M | 0.34% | 62 |
|
|
2024
Q4 | $1.7B | Buy |
3,272,531
+26,287
| +0.8% | +$14.5M | 0.34% | 59 |
|
|
2024
Q3 | $2.01B | Sell |
3,246,244
-31,543
| -1% | -$18.7M | 0.41% | 46 |
|
|
2024
Q2 | $1.81B | Buy |
3,277,787
+94,822
| +3% | +$54.3M | 0.41% | 50 |
|
|
2024
Q1 | $1.85B | Sell |
3,182,965
-61,408
| -2% | -$34.5M | 0.42% | 47 |
|
|
2023
Q4 | $1.72B | Sell |
3,244,373
-1,351,086
| -29% | -$654M | 0.4% | 47 |
|
|
2023
Q3 | $2.33B | Sell |
4,595,459
-130,918
| -3% | -$69.8M | 0.63% | 29 |
|
|
2023
Q2 | $2.47B | Buy |
4,726,377
+1,829,301
| +63% | +$987M | 0.65% | 29 |
|
|
2023
Q1 | $1.67B | Buy |
2,897,076
+212,706
| +8% | +$120M | 0.47% | 42 |
|
|
2022
Q4 | $1.48B | Buy |
2,684,370
+143,749
| +6% | +$76.2M | 0.42% | 50 |
|
|
2022
Q3 | $1.29B | Buy |
2,540,621
+178,556
| +8% | +$99.9M | 0.41% | 48 |
|
|
2022
Q2 | $1.28B | Sell |
2,362,065
-119,371
| -5% | -$65.7M | 0.38% | 54 |
|
|
2022
Q1 | $1.47B | Sell |
2,481,436
-24,158
| -1% | -$13.9M | 0.37% | 52 |
|
|
2021
Q4 | $1.67B | Buy |
2,505,594
+51,474
| +2% | +$32.1M | 0.38% | 49 |
|
|
2021
Q3 | $1.4B | Sell |
2,454,120
-98,123
| -4% | -$53.9M | 0.37% | 53 |
|
|
2021
Q2 | $1.29B | Sell |
2,552,243
-14,751
| -0.6% | -$6.96M | 0.34% | 56 |
|
|
2021
Q1 | $1.17B | Buy |
2,566,994
+130,247
| +5% | +$62.2M | 0.34% | 61 |
|
|
2020
Q4 | $1.13B | Sell |
2,436,747
-130,521
| -5% | -$61.2M | 0.33% | 62 |
|
|
2020
Q3 | $1.13B | Buy |
2,567,268
+171,288
| +7% | +$70.8M | 0.4% | 48 |
|
|
2020
Q2 | $868M | Buy |
2,395,980
+87,406
| +4% | +$29.3M | 0.34% | 66 |
|
|
2020
Q1 | $655M | Sell |
2,308,574
-32,470
| -1% | -$10.2M | 0.32% | 70 |
|
|
2019
Q4 | $761M | Sell |
2,341,044
-149,982
| -6% | -$45.5M | 0.27% | 76 |
|
|
2019
Q3 | $726M | Buy |
2,491,026
+187,367
| +8% | +$53.7M | 0.29% | 74 |
|
|
2019
Q2 | $677M | Buy |
2,303,659
+75,814
| +3% | +$20.9M | 0.27% | 74 |
|
|
2019
Q1 | $610M | Buy |
2,227,845
+95,739
| +4% | +$23.8M | 0.26% | 73 |
|
|
2018
Q4 | $477M | Buy |
2,132,106
+12,743
| +0.6% | +$2.99M | 0.23% | 91 |
|
|
2018
Q3 | $518M | Buy |
2,119,363
+39,290
| +2% | +$9.04M | 0.22% | 92 |
|
|
2018
Q2 | $431M | Buy |
2,080,073
+68,342
| +3% | +$14.5M | 0.19% | 98 |
|
|
2018
Q1 | $415M | Buy |
2,011,731
+30,355
| +2% | +$6.37M | 0.19% | 99 |
|
|
2017
Q4 | $376M | Buy |
1,981,376
+1,840
| +0.1% | +$352K | 0.17% | 113 |
|
|
2017
Q3 | $375M | Buy |
1,979,536
+68,816
| +4% | +$12.5M | 0.18% | 105 |
|
|
2017
Q2 | $333M | Buy |
1,910,720
+16,187
| +0.9% | +$2.72M | 0.17% | 110 |
|
|
2017
Q1 | $291M | Buy |
1,894,533
+114,486
| +6% | +$17.5M | 0.16% | 117 |
|
|
2016
Q4 | $251M | Buy |
1,780,047
+253,702
| +17% | +$37.4M | 0.14% | 124 |
|
|
2016
Q3 | $243M | Sell |
1,526,345
-197,978
| -11% | -$30.5M | 0.14% | 127 |
|
|
2016
Q2 | $255M | Buy |
1,724,323
+59,909
| +4% | +$8.84M | 0.15% | 106 |
|
|
2016
Q1 | $236M | Buy |
1,664,414
+28,314
| +2% | +$3.79M | 0.15% | 107 |
|
|
2015
Q4 | $232M | Buy |
1,636,100
+934,111
| +133% | +$125M | 0.15% | 109 |
|
|
2015
Q3 | $85.8M | Buy |
701,989
+470,499
| +203% | +$61.3M | 0.06% | 211 |
|
|
2015
Q2 | $30M | Sell |
231,490
-95,178
| -29% | -$12.4M | 0.02% | 600 |
|
|
2015
Q1 | $43.9M | Buy |
326,668
+65,389
| +25% | +$8.43M | 0.03% | 441 |
|
|
2014
Q4 | $32.7M | Buy |
261,279
+57,126
| +28% | +$6.95M | 0.02% | 597 |
|
|
2014
Q3 | $24.8M | Buy |
204,153
+23,767
| +13% | +$2.89M | 0.02% | 689 |
|
|
2014
Q2 | $21.3M | Sell |
180,386
-348,986
| -66% | -$41.1M | 0.01% | 780 |
|
|
2014
Q1 | $63.7M | Buy |
529,372
+33,650
| +7% | +$4M | 0.05% | 291 |
|
|
2013
Q4 | $55.2M | Buy |
495,722
+356,979
| +257% | +$35.5M | 0.04% | 344 |
|
|
2013
Q3 | $12.8M | Sell |
138,743
-17,970
| -11% | -$1.63M | 0.01% | 997 |
|
|
2013
Q2 | $13.3M | Buy |
+156,713
| New | +$13M | 0.01% | 890 |
|
Other funds holding TMO
VCM
Royal Bank of Canada's TMO Position: Q1 2026 in Review
Royal Bank of Canada reduced its Thermo Fisher Scientific (TMO) stake by 3% in Q1 2026, selling an estimated $66.4M and leaving 3,913,903 shares worth $1.92B. The position accounts for 0.34% of the portfolio, ranked #56.
Royal Bank of Canada first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.47B in Q2 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Royal Bank of Canada held 3,913,903 shares of Thermo Fisher Scientific worth $1.92B as of Q1 2026.
- Royal Bank of Canada sold 122,343 Thermo Fisher Scientific shares in Q1 2026, an estimated $66.4M.
- Thermo Fisher Scientific made up 0.34% of Royal Bank of Canada's portfolio in Q1 2026, its #56 holding.
- Royal Bank of Canada first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Thermo Fisher Scientific position peaked at $2.47B in Q2 2023.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.